Asia-Pacific Veterinary Healthcare Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 10.20 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Asia-Pacific Veterinary Healthcare Market Analysis
The Asia-Pacific Veterinary Healthcare Market is projected to register a CAGR of nearly 10.2% during the forecast period (2022-2027).
The studied market witnessed a short-term impact owing to the decreased visits to veterinary hospitals and clinics during the initial phase of the Covid-19 outbreak. However, owing to the increasing adoption of pets during the pandemic in the countries across the Asia-Pacific region the focus on veterinary healthcare services increased. The government and non-government organizations for animals have taken steps forward to start new initiatives. Additionally, at the later phase of the pandemic, many service providers and organizations focused on veterinary healthcare to protect animals from Covid-19 infection in the region. For instance, in December 2021, with an investment of up to USD 10 million the Asian Development Bank (ADB) signed an agreement to take a stake in Zenex Animal Health India Private Limited (Zenex) to increase Zenex's production and distribution of quality animal health care products and help boost farmer incomes by mitigating livestock disease risk. ADB and Zenex will also work together on containing antimicrobial resistance across India, Bangladesh, Nepal, and Sri Lanka. Therefore, based on the factors stated above the Covid-19 pandemic is anticipated to have a significant impact on the market studied.
The Asia Pacific veterinary healthcare market is projected to have significant growth owing to the factors such as advanced technology leading to innovations in animal healthcare and increasing productivity at the risk of an emerging zoonosis. Currently, diagnostic lab equipment is easy to acquire, and the advancements in diagnostic equipment aid in providing better results efficiently. Furthermore, they can seamlessly provide electronic data charts for animals. Other factors responsible for the growth of the market studied include an increase in the number of the pet as well as farm animals and growing technological advancements in animal healthcare.
In the article 'Spike in Ownership Boosts Pet Care Retail Biz' published in September 2021 stated that pet ownership increased in India recently with an estimated pet population of 28-29 million, and dogs make up the highest pet ownership. On the other hand, the source also mentioned that cats have experienced a more recent increase in adoption and ownership, largely because of their perception that cats are more independent than dogs and need less maintenance. This increasing adoption of pets is anticipated to create opportunities for veterinary healthcare services and products in the country. Thus, the studied market is expected to boom in the region over the forecast period.
Moreover, the continuous involvement of market players in collaboration, partnerships, and development of innovative products is increasing in the region recently. For instance, in August 2021, QBiotics Group Limited (QBiotics), an Australian life sciences company developing novel small molecule anticancer and wound healing pharmaceuticals, received approval from the Australian Pesticides and Veterinary Medicines Authority (APVMA) for the veterinary product STELFONTA (tigilanol tiglate). This approval represents Australia's first pharmaceutical treatment available for all grades of canine non-metastatic MCT. Furthermore, precision management systems have been used explicitly to improve animal welfare. For instance, real-time automatic video monitoring of chicken houses can be used to detect zones of low or abnormal occupation and malfunctioning feed. It can trigger an automatic alarm to alert the owner. These are several developments that are conducted in the Asia-pacific region, which are further expected to bolster the market growth.
Thus, owing to the factors mentioned above, the Asia-Pacific veterinary healthcare market is expected to exhibit good growth over the forecast period. However, the increasing cost of veterinary services coupled with the lack of infrastructure and funding and the use of counterfeit medicines might hamper the market growth over the analysis period.
Asia-Pacific Veterinary Healthcare Market Trends
This section covers the major market trends shaping the APAC Veterinary Healthcare Market according to our research experts:
Vaccines Segment is Expected to Dominate the Market Over the Forecast Period
Vaccines are comprised of viruses, bacteria, or other disease-causing organisms that have been killed or altered so that they cannot cause any disease, thus, boosting immunity. New advanced vaccines, which contain genetically engineered components derived from those disease agents, have been manufactured. Factors such as continuous innovations, growing awareness about animal health, increasing investments by government organizations, increasing demand for animal protein, including milk, meat, eggs, and fish, and rising healthcare expenditure for companion animals are attributed to the segment growth.
A strong foothold of key market players offering a wide range of products in the arena of veterinary vaccines is likely to fuel the segmental growth over the upcoming years. Additionally, market players are focusing on the launch of new vaccines to enhance their market presence across the Asia-pacific region. For example, in June 2022, the government of India launched Ancovax, a Covid-19 vaccine for animals such as dogs, lions, leopards, mice, and rabbits.
In addition, governments across the region are currently more focused on vaccination drives and programs to aid several diseases in companion and livestock animals. For instance, in March 2022, Indonesia's Ministry of Agriculture launched a mass vaccination program in the province of Riau, with the support of the Food and Agriculture Organization of the United Nations (FAO) and other partners to contain the spread of lumpy skin disease (LSD) in cattle. Such developments across the countries are projected to significantly impact the segment growth.
Therefore, the above-mentioned factors are expected to contribute to the segment growth over the forecast period.
Asia-Pacific Veterinary Healthcare Industry Overview
The Asia-Pacific Veterinary Healthcare Market is competitive, and the threat of new entrants is high owing to various opportunities globally. The players in the Asia-Pacific veterinary healthcare market are primarily focusing on various growth strategies, such as collaborations, partnerships, agreements, mergers, and acquisitions, to enhance their market presence. Some of the major market players include Bayer Healthcare, Boehringer Ingelheim, Ceva Animal Health, Inc., Elanco, Merck Animal Health, and Zoetis, among others.
Asia-Pacific Veterinary Healthcare Market Leaders
-
Vetoquinol
-
Elanco
-
Boehringer Ingelheim International GmbH
-
Merck & Co., Inc.
-
Ceva
*Disclaimer: Major Players sorted in no particular order
Asia-Pacific Veterinary Healthcare Market News
- In May 2022, to control the economically essential livestock diseases and to undertake the necessary functions related to animal health in the country, the Central Government of India implemented the Livestock Health and Disease Control Schemes with a budget of Rs 525 crores.
- In March 2022, Hacarus Inc, launched its ECG platform, along with DS Pharma Animal Health. The device measures and analyzes the heart condition of dogs, to aid in the early detection of cardiac disease, the second leading cause of death for canines.
Asia-Pacific Veterinary Healthcare Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
-
4.1 Market Overview
- 4.1.1 Advanced Technology is Leading to Innovations in Animal Healthcare
- 4.1.2 Growing Adoption of Animals Coupled with the Risk of Emerging Zoonosis
-
4.2 Market Restraints
- 4.2.1 Increasing Cost of Veterinary Services Couple with the Lack of Infrastructure and Funding
- 4.2.2 Use of Counterfeit Medicines
-
4.3 Porter's Five Forces Analysis
- 4.3.1 Threat of New Entrants
- 4.3.2 Bargaining Power of Buyers/Consumers
- 4.3.3 Bargaining Power of Suppliers
- 4.3.4 Threat of Substitute Products
- 4.3.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Product
- 5.1.1 By Therapeutics
- 5.1.1.1 Vaccines
- 5.1.1.2 Parasiticides
- 5.1.1.3 Anti-infectives
- 5.1.1.4 Medical Feed Additives
- 5.1.1.5 Other Therapeutics
- 5.1.2 By Diagnostics
- 5.1.2.1 Immunodiagnostic Tests
- 5.1.2.2 Molecular Diagnostics
- 5.1.2.3 Diagnostic Imaging
- 5.1.2.4 Clinical Chemistry
- 5.1.2.5 Other Diagnostics
-
5.2 By Animal Type
- 5.2.1 Dogs
- 5.2.2 Cats
- 5.2.3 Horses
- 5.2.4 Other Animals
-
5.3 Geography
- 5.3.1 China
- 5.3.2 Japan
- 5.3.3 India
- 5.3.4 Australia
- 5.3.5 South Korea
- 5.3.6 Rest of Asia-Pacific
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Zoetis
- 6.1.2 Merck & Co., Inc.
- 6.1.3 Vetoquinol
- 6.1.4 Elanco
- 6.1.5 Ceva
- 6.1.6 Virbac
- 6.1.7 IDEXX Laboratories
- 6.1.8 Phibro Animal Health
- 6.1.9 Boehringer Ingelheim International GmbH
- 6.1.10 Idexx laboratories
- 6.1.11 Mars Inc.
- 6.1.12 CVS Group PLC
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityAsia-Pacific Veterinary Healthcare Industry Segmentation
As per the scope of this report, the Asia-Pacific veterinary healthcare market comprises of therapeutic and diagnostic products and solutions for companion and farm animals. The Asia-Pacific Veterinary Healthcare market is segmented by Product (Therapeutics and Diagnostics), Animal Type, (Dogs, Cats, Horses and Other Animals), and Geography (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific). The report offers the value (in USD million) for the above segments.
| By Product | By Therapeutics | Vaccines |
| Parasiticides | ||
| Anti-infectives | ||
| Medical Feed Additives | ||
| Other Therapeutics | ||
| By Product | By Diagnostics | Immunodiagnostic Tests |
| Molecular Diagnostics | ||
| Diagnostic Imaging | ||
| Clinical Chemistry | ||
| Other Diagnostics | ||
| By Animal Type | Dogs | |
| Cats | ||
| Horses | ||
| Other Animals | ||
| Geography | China | |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific |
Asia-Pacific Veterinary Healthcare Market Research FAQs
What is the current Asia-Pacific Veterinary Healthcare Market size?
The Asia-Pacific Veterinary Healthcare Market is projected to register a CAGR of 10.20% during the forecast period (2024-2029)
Who are the key players in Asia-Pacific Veterinary Healthcare Market?
Vetoquinol, Elanco, Boehringer Ingelheim International GmbH, Merck & Co., Inc. and Ceva are the major companies operating in the Asia-Pacific Veterinary Healthcare Market.
Which is the fastest growing region in Asia-Pacific Veterinary Healthcare Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Asia-Pacific Veterinary Healthcare Market?
In 2024, the North America accounts for the largest market share in Asia-Pacific Veterinary Healthcare Market.
What years does this Asia-Pacific Veterinary Healthcare Market cover?
The report covers the Asia-Pacific Veterinary Healthcare Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Asia-Pacific Veterinary Healthcare Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
APAC Animal Health Industry Report
Statistics for the 2024 APAC Animal Health market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. APAC Animal Health analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
